CABA - Cabaletta Bio, Inc.
1.19
-0.020 -1.681%
Share volume: 372,400
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.21
-0.02
-0.02%
Summary score
14%
Profitability
4%
Dept financing
15%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.75%
Return on assets
-5.57%
Return on sales
0%
Return on invested capital
-1008.18%
Total debt ratio
46.48%
Debt ratio change over timeo
0%
Current Ratio
36.42%
Quick Ratio
0%
Cash Position Ratio
35.57%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
2.75%
Return on assets
-5.57%
Return on sales
0%
Return on invested capital
-1008.18%
Total debt ratio
46.48%
Debt ratio change over timeo
0%
Current Ratio
36.42%
Quick Ratio
0%
Cash Position Ratio
35.57%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-5.68%
Return on assets
-5.85%
Return on sales
0%
Return on invested capital
310.19%
Total debt ratio
2.41%
Debt ratio change over time
0%
Current Ratio
41.19%
Quick Ratio
0%
Cash Position Ratio
40.23%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CABA | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 2.75% | 10.89% | 8.33% | -11.96% |
| Return on assets | -5.57% | 3.55% | 4.46% | -8.17% |
| Return on sales | 0% | 42.5% | 41.63% | -215.46% |
| Return on invested capital | -1008.18% | 8.18% | 7.65% | -50.82% |
| Profitability | 6% | 95% | 92% | 0% |
| Total debt ratio | 46.48% | 72.64% | 65.79% | 38.8% |
| Debt ratio change over time | 0% | 0% | 417.27% | 0% |
| Dept financing | 16% | 25% | 48% | 13% |
| Current Ratio | 36.42% | 2.2% | 3.22% | 3.41% |
| Quick Ratio | 0% | 1.91% | 3.12% | 3.34% |
| Cash Position Ratio | 35.57% | 0.68% | 2.56% | 3.18% |
| Liquididy | 50% | 28% | 24% | 29% |
| Short-term ratios | CABA | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 2.75% | 18.76% | 5.41% | -11.96% |
| Return on assets | -5.57% | 3.92% | 1.79% | -8.17% |
| Return on sales | 0% | 39.67% | 19.59% | -215.46% |
| Return on invested capital | -1008.18% | 8.77% | 5.66% | -50.82% |
| Profitability | 4% | 100% | 47% | 0% |
| Total debt ratio | 46.48% | 82.97% | 63.97% | 38.8% |
| Debt ratio change over time | 0% | 0% | 0.73% | 0% |
| Dept financing | 14% | 25% | 44% | 12% |
| Current Ratio | 36.42% | 2.2% | 3.22% | 3.41% |
| Quick Ratio | 0% | 1.91% | 3.12% | 3.34% |
| Cash Position Ratio | 35.57% | 0.68% | 2.56% | 3.18% |
| Liquididy | 50% | 16% | 27% | 30% |
